Topical cyclosporine in the treatment of allergic conjunctivitis: A meta-analysis

Ophthalmology

Volumn 120, Issue 11, 2013, Pages 2197-2203

  Wan, Kelvin Ho Nam ^a,b   Chen, Li Jia ^a,b   Rong, Shi Song ^b   Pang, Chi Pui ^a,b   Young, Alvin L ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; EYE DROPS; PLACEBO; STEROID;

ALLERGIC CONJUNCTIVITIS; APPLICATION SITE REACTION; APPLICATION SITE STINGING; ARTICLE; BURNING SENSATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCORING SYSTEM; STEROID THERAPY; SYSTEMATIC REVIEW;

ADMINISTRATION, TOPICAL; CONJUNCTIVITIS, ALLERGIC; CYCLOSPORINE; DATABASES, FACTUAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; OPHTHALMIC SOLUTIONS; TREATMENT OUTCOME;

EID: 84887188239     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2013.03.044     Document Type: Article

References (27)

1. M. Calonge Classification of ocular atopic/allergic disorders and conditions: an unsolved problem Acta Ophthalmol Scand Suppl 228 1999 10 13
2. E. von Mutius, F.D. Martinez, and C. Fritzsch Prevalence of asthma and atopy in two areas of West and East Germany Am J Respir Crit Care Med 149 1994 358 364
3. M.B. Abelson, L. Smith, and M. Chapin Ocular allergic disease: mechanisms, disease sub-types, treatment Ocul Surf 1 2003 127 149
4. S.J. Ono, and M.B. Abelson Allergic conjunctivitis: update on pathophysiology and prospects for future treatment J Allergy Clin Immunol 115 2005 118 122
5. R. Belfort, P. Marbeck, C.C. Hsu, and D. Freitas Epidemiological study of 134 subjects with allergic conjunctivitis Acta Ophthalmol Scand Suppl 230 2000 38 40
6. A. Leonardi, C. De Dominicis, and L. Motterle Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities Curr Opin Allergy Clin Immunol 7 2007 429 435
7. A. Leonardi Emerging drugs for ocular allergy Expert Opin Emerg Drugs 10 2005 505 520
8. L. Bielory Ocular allergy treatment Immunol Allergy Clin North Am 28 2008 189 224 vii
9. S. Bonini, S. Bonini, and A. Lambiase Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup Ophthalmology 107 2000 1157 1163
10. W.J. Power, P. Mullaney, M. Farrell, and L.M. Collum Effect of topical cyclosporin A on conjunctival T cells in patients with secondary Sjögren's syndrome Cornea 12 1993 507 511
11. A.M. el-Asrar, K.F. Tabbara, and K. Geboes An immunohistochemical study of topical cyclosporine in vernal keratoconjunctivitis Am J Ophthalmol 121 1996 156 161
12. M. Hingorani, L. Moodaley, and V.L. Calder A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis Ophthalmology 105 1998 1715 1720
13. M. Daniell, M. Constantinou, H.T. Vu, and H.R. Taylor Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis Br J Ophthalmol 90 2006 461 464
14. C. Lefebvre, E. Manheimer, J. Glanville, and Cochrane Information Retrieval Methods Group 6.4.11: search filters J.P. Higgins, D.G. Altman, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] 2011 The Cochrane Collaboration Available at http://handbook. cochrane.org/ Accessed March 4, 2013
15. Deeks JJ, Higgins JP, Altman DG, Cochrane Statistical Methods Group. Analysing data and undertaking meta-analyses. In: Higgins JP, Altman DG, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Available at: http://handbook.cochrane.org/. Accessed March 4, 2013.
16. J.P. Higgins, and J.J. Deeks 7.7.3: data extraction for continuous outcomes J.P. Higgins, D.G. Altman, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] 2011 The Cochrane Collaboration Available at http://handbook.cochrane.org/ Accessed March 4, 2013
17. J.P. Higgins, D.G. Altman, J.A. Sterne, Cochrane Statistical Methods Group, and Cochrane Bias Methods Group Assessing risk of bias in included studies J.P. Higgins, D.G. Altman, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] 2011 The Cochrane Collaboration Available at http://handbook.cochrane.org/ Accessed March 4, 2013
18. A. Kilic, and B. Gurler Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis Can J Ophthalmol 41 2006 693 698
19. N. Pucci, E. Novembre, and A. Cianferoni Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis Ann Allergy Asthma Immunol 89 2002 298 303
20. A.G. Secchi, M.S. Tognon, and A. Leonardi Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis Am J Ophthalmol 110 1990 641 645
21. E.K. Akpek, J.K. Dart, and S. Watson A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis Ophthalmology 111 2004 476 482
22. V. Gupta, and P.K. Sahu Topical cyclosporin A in the management of vernal keratoconjunctivitis Eye (Lond) 15 2001 39 41
23. S.D. Jaanus Anti-inflammatory drugs J.D. Bartlett, S.D. Jaanus, Clinical Ocular Pharmacology 2nd ed. 1989 Butterworths Boston 163 197
24. L.D. Barber, S.C. Pflugfelder, J. Tauber, and G.N. Foulks Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years Ophthalmology 112 2005 1790 1794
25. K. Sall, O.D. Stevenson, T.K. Mundorf, B.L. Reis CsA Phase 3 Study Group Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease Ophthalmology 107 2000 631 639
26. N.N. Wong Vernal vs. atopic keratoconjunctivitis Clin Eye Vis Care 11 1999 13 16
27. L. Spadavecchia, P. Fanelli, and R. Tesse Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood Pediatr Allergy Immunol 17 2006 527 532